vs
Side-by-side financial comparison of Agilent Technologies (A) and Roper Technologies (ROP). Click either name above to swap in a different company.
Roper Technologies is the larger business by last-quarter revenue ($2.1B vs $1.8B, roughly 1.2× Agilent Technologies). Agilent Technologies runs the higher net margin — 17.0% vs 15.8%, a 1.2% gap on every dollar of revenue. On growth, Roper Technologies posted the faster year-over-year revenue change (11.3% vs 7.0%). Roper Technologies produced more free cash flow last quarter ($507.0M vs $175.0M). Over the past eight quarters, Roper Technologies's revenue compounded faster (10.5% CAGR vs 6.9%).
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emissi...
Roper Technologies, Inc. is a holding company that owns companies in the technology sector.
A vs ROP — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.8B | $2.1B |
| Net Profit | $305.0M | $331.0M |
| Gross Margin | 52.6% | 69.4% |
| Operating Margin | 19.6% | 27.2% |
| Net Margin | 17.0% | 15.8% |
| Revenue YoY | 7.0% | 11.3% |
| Net Profit YoY | -4.1% | 53.7% |
| EPS (diluted) | $1.07 | $4.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.8B | $2.1B | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $1.7B | $2.0B | ||
| Q2 25 | $1.7B | $1.9B | ||
| Q1 25 | $1.7B | $1.9B | ||
| Q4 24 | $1.7B | $1.9B | ||
| Q3 24 | $1.6B | $1.8B | ||
| Q2 24 | $1.6B | $1.7B |
| Q1 26 | $305.0M | $331.0M | ||
| Q4 25 | $434.0M | $428.4M | ||
| Q3 25 | $336.0M | $398.5M | ||
| Q2 25 | $215.0M | $378.3M | ||
| Q1 25 | $318.0M | $331.1M | ||
| Q4 24 | $351.0M | $462.3M | ||
| Q3 24 | $282.0M | $367.9M | ||
| Q2 24 | $308.0M | $337.1M |
| Q1 26 | 52.6% | 69.4% | ||
| Q4 25 | 53.2% | 69.5% | ||
| Q3 25 | 51.1% | 69.5% | ||
| Q2 25 | 51.9% | 69.2% | ||
| Q1 25 | 53.5% | 68.7% | ||
| Q4 24 | 53.9% | 68.3% | ||
| Q3 24 | 54.2% | 69.2% | ||
| Q2 24 | 54.4% | 69.5% |
| Q1 26 | 19.6% | 27.2% | ||
| Q4 25 | 23.8% | 28.6% | ||
| Q3 25 | 20.7% | 28.4% | ||
| Q2 25 | 18.0% | 28.2% | ||
| Q1 25 | 22.4% | 27.9% | ||
| Q4 24 | 24.0% | 28.0% | ||
| Q3 24 | 21.1% | 28.1% | ||
| Q2 24 | 23.1% | 28.8% |
| Q1 26 | 17.0% | 15.8% | ||
| Q4 25 | 23.3% | 20.8% | ||
| Q3 25 | 19.3% | 19.8% | ||
| Q2 25 | 12.9% | 19.5% | ||
| Q1 25 | 18.9% | 17.6% | ||
| Q4 24 | 20.6% | 24.6% | ||
| Q3 24 | 17.9% | 20.8% | ||
| Q2 24 | 19.6% | 19.6% |
| Q1 26 | $1.07 | $4.87 | ||
| Q4 25 | $1.53 | $3.97 | ||
| Q3 25 | $1.18 | $3.68 | ||
| Q2 25 | $0.75 | $3.49 | ||
| Q1 25 | $1.11 | $3.06 | ||
| Q4 24 | $1.23 | $4.29 | ||
| Q3 24 | $0.97 | $3.40 | ||
| Q2 24 | $1.05 | $3.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | $382.9M |
| Total DebtLower is stronger | $3.0B | $9.7B |
| Stockholders' EquityBook value | $6.9B | $18.8B |
| Total Assets | $12.8B | $34.6B |
| Debt / EquityLower = less leverage | 0.44× | 0.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $1.8B | $382.9M | ||
| Q4 25 | $1.8B | $297.4M | ||
| Q3 25 | $1.5B | $320.0M | ||
| Q2 25 | $1.5B | $242.4M | ||
| Q1 25 | $1.5B | $372.8M | ||
| Q4 24 | $1.3B | $188.2M | ||
| Q3 24 | $1.8B | $269.6M | ||
| Q2 24 | $1.7B | $251.5M |
| Q1 26 | $3.0B | $9.7B | ||
| Q4 25 | $3.0B | $9.3B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | — | ||
| Q1 25 | $3.3B | — | ||
| Q4 24 | $3.3B | $7.6B | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | $6.9B | $18.8B | ||
| Q4 25 | $6.7B | $19.9B | ||
| Q3 25 | $6.4B | $20.0B | ||
| Q2 25 | $6.1B | $19.6B | ||
| Q1 25 | $6.0B | $19.2B | ||
| Q4 24 | $5.9B | $18.9B | ||
| Q3 24 | $5.9B | $18.5B | ||
| Q2 24 | $6.2B | $18.1B |
| Q1 26 | $12.8B | $34.6B | ||
| Q4 25 | $12.7B | $34.6B | ||
| Q3 25 | $12.2B | $34.6B | ||
| Q2 25 | $12.2B | $33.2B | ||
| Q1 25 | $11.9B | $31.4B | ||
| Q4 24 | $11.8B | $31.3B | ||
| Q3 24 | $11.0B | $31.6B | ||
| Q2 24 | $10.9B | $29.8B |
| Q1 26 | 0.44× | 0.52× | ||
| Q4 25 | 0.45× | 0.47× | ||
| Q3 25 | 0.53× | — | ||
| Q2 25 | 0.55× | — | ||
| Q1 25 | 0.56× | — | ||
| Q4 24 | 0.57× | 0.40× | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $268.0M | — |
| Free Cash FlowOCF − Capex | $175.0M | $507.0M |
| FCF MarginFCF / Revenue | 9.7% | 24.2% |
| Capex IntensityCapex / Revenue | 5.2% | 0.5% |
| Cash ConversionOCF / Net Profit | 0.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | $993.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $738.0M | ||
| Q3 25 | $362.0M | $869.5M | ||
| Q2 25 | $221.0M | $404.1M | ||
| Q1 25 | $431.0M | $528.7M | ||
| Q4 24 | $481.0M | $722.2M | ||
| Q3 24 | $452.0M | $755.4M | ||
| Q2 24 | $333.0M | $384.1M |
| Q1 26 | $175.0M | $507.0M | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
| Q1 26 | 9.7% | 24.2% | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
| Q1 26 | 5.2% | 0.5% | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | 1.72× | ||
| Q3 25 | 1.08× | 2.18× | ||
| Q2 25 | 1.03× | 1.07× | ||
| Q1 25 | 1.36× | 1.60× | ||
| Q4 24 | 1.37× | 1.56× | ||
| Q3 24 | 1.60× | 2.05× | ||
| Q2 24 | 1.08× | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
ROP
Segment breakdown not available.
